Elan: Wizard wheeze or total warlocks
This article was originally published in Scrip
Money is Harry Potter. It can change anything into anything else. I use money to convert words into housing and clothes for my children. My children use money to convert a vague sense of parental obligation into X-Box games (or spatial awareness- and reaction-training aids, as I think of them). Pension funds convert thrift into infrastructure, and into manufacturing, and – somewhere in a long chain of venturesome transformation – into R&D that might itself eventually be transformed into drugs.
You may also be interested in...
Charting the executive gender mix across 384 companies from mid-2014 to mid-2019 demonstrates that C-suite gender balance in pharma is moving towards a point that more closely reflects its total workforce, but that progress has been slow and that there is a long road to travel before the transformation is complete.
With gender diversity only slowly increasing in biopharma c-suites, Scrip spoke to executives from five companies about the importance of change.
In a flat month, the market value of big pharma changed little overall. But the balance of power in immuno-oncology did shift significantly.